Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 6
2012 7
2013 8
2014 12
2015 5
2016 11
2017 14
2018 10
2019 6
2020 2
2021 2
2022 5
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Trends of Diabetes Epidemic in Korea.
Bae JC. Bae JC. Diabetes Metab J. 2018 Oct;42(5):377-379. doi: 10.4093/dmj.2018.0194. Diabetes Metab J. 2018. PMID: 30362303 Free PMC article. No abstract available.
No More NAFLD: The Term Is Now MASLD.
Bae JC. Bae JC. Endocrinol Metab (Seoul). 2024 Feb;39(1):92-94. doi: 10.3803/EnM.2024.103. Epub 2024 Feb 13. Endocrinol Metab (Seoul). 2024. PMID: 38347708 Free PMC article. No abstract available.
Diabetes Drugs and Cardiovascular Safety.
Bae JC. Bae JC. Endocrinol Metab (Seoul). 2016 Jun;31(2):239-44. doi: 10.3803/EnM.2016.31.2.239. Epub 2016 Jun 10. Endocrinol Metab (Seoul). 2016. PMID: 27302713 Free PMC article. Review.
Klinefelter Syndrome and Metabolic Disorder.
Bae JC. Bae JC. Endocrinol Metab (Seoul). 2016 Dec;31(4):535-536. doi: 10.3803/EnM.2016.31.4.535. Endocrinol Metab (Seoul). 2016. PMID: 28029025 Free PMC article. No abstract available.
Subclinical Cushing's Syndrome and Metabolic Disorder.
Bae JC. Bae JC. Endocrinol Metab (Seoul). 2014 Dec 29;29(4):441-2. doi: 10.3803/EnM.2014.29.4.441. Endocrinol Metab (Seoul). 2014. PMID: 25559573 Free PMC article. No abstract available.
A double-blind, Randomized controlled trial on glucose-lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase-4 inhibitor therapy: REFIND study.
Ryang S, Kim SS, Bae JC, Han JM, Kwon SK, Kim YI, Nam-Goong IS, Kim ES, Kim MK, Lee CW, Yoo S, Koh G, Kwon MJ, Park JH, Kim IJ. Ryang S, et al. Among authors: bae jc. Diabetes Obes Metab. 2022 Sep;24(9):1800-1809. doi: 10.1111/dom.14766. Epub 2022 Jun 9. Diabetes Obes Metab. 2022. PMID: 35581902 Free PMC article. Clinical Trial.
85 results